These studies focused on RA patients who had been hospitalized with infections who were under anti-tumour necrosis factor (anti-TNF) therapy and analysed the risk of subsequent hospitalizations because of infections under continued therapy. The gene discussed is TNF; the disease is rheumatoid arthritis.